Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.49 CHF | +0.45% | +6.12% | +10.16% |
13/05 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
10/05 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.16% | 209B | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
-8.14% | 203B | |
+8.12% | 165B | |
-1.42% | 161B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Transcript : Novartis AG, Q4 2018 Earnings Call, Jan 30, 2019